Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Inclusion Criteria

• •1. Patient is male and aged \>18 years old.
• •2. History of localized adenocarcinoma of the prostate with prior curative intent treatment.
• •3. An elevated PSA, clinically suspicious for biochemically recurrent disease:
• •* Following Radical Prostatectomy: PSA \>0.2 ng/mL
• •* Following Radiotherapy: nadir +2 ng/mL.
• •4. Potentially eligible for salvage therapy with curative intent.